Effective nonapical left ventricular pacing with quadripolar leads for cardiac resynchronization therapy.
暂无分享,去创建一个
C. Lavalle | S. Valsecchi | M. Sassara | D. D. Della Rocca | S. Donzelli | G. Forleo | L. Santini | G. Covino | A. Gasperetti | F. Solimene | G. Mitacchione | G. Savarese | S. Badolati | V. Schillaci | M. Lovecchio | M. Schiavone | C. Gerosa | Mariolina Lovecchio
[1] M. Bertini,et al. Single- and multi-site pacing strategies for optimal cardiac resynchronization therapy: impact on device longevity and therapy cost , 2020, Journal of Interventional Cardiac Electrophysiology.
[2] A. Curnis,et al. Clinical and economic impact of multipoint left ventricular pacing: A comparative analysis from the Italian registry on multipoint pacing in cardiac resynchronization therapy (IRON‐MPP) , 2020, Journal of cardiovascular electrophysiology.
[3] G. Boriani,et al. Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads , 2018, Scientific Reports.
[4] C. Rinaldi,et al. Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions , 2018, Heart Failure Reviews.
[5] F. Leyva,et al. Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization , 2017, Journal of the American Heart Association.
[6] C. Leclercq,et al. Avoiding non-responders to cardiac resynchronization therapy: a practical guide , 2016, European heart journal.
[7] L. Di Biase,et al. Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP) , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[8] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[9] Nigel Gupta,et al. Performance of Anatomically Designed Quadripolar Left Ventricular Leads: Results from the NAVIGATE X4 Clinical Trial , 2016, Journal of cardiovascular electrophysiology.
[10] Michael Cao,et al. Reduced Mortality Associated With Quadripolar Compared to Bipolar Left Ventricular Leads in Cardiac Resynchronization Therapy. , 2016, JACC. Clinical electrophysiology.
[11] J. Brachmann,et al. Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads: The EffaceQ Study , 2015, Pacing and clinical electrophysiology : PACE.
[12] C. Morillo,et al. Left Ventricular Three‐Dimensional Quadripolar Lead Acute Clinical Study: The LILAC Study , 2015, Pacing and clinical electrophysiology : PACE.
[13] A. Natale,et al. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] J. Ottervanger,et al. Incidence of lead dislodgement, malfunction and perforation during the first year following device implantation , 2014, Netherlands Heart Journal.
[15] R. Verlato,et al. Incremental Value of Larger Interventricular Conduction Time in Improving Cardiac Resynchronization Therapy Outcome in Patients with Different QRS Duration , 2014, Journal of cardiovascular electrophysiology.
[16] J. Healey,et al. Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). , 2014, Canadian Journal of Cardiology.
[17] A. Natale,et al. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study , 2014, Journal of Interventional Cardiac Electrophysiology.
[18] K. Dickstein,et al. Meta‐analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy , 2013, European journal of heart failure.
[19] M. Biffi,et al. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[20] A. Natale,et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. , 2012, Heart rhythm.
[21] Erwan Donal,et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. , 2012, European heart journal.
[22] G. Boriani,et al. Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? , 2011, Pacing and clinical electrophysiology : PACE.
[23] Kenneth A. Ellenbogen,et al. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy , 2011, European heart journal.
[24] Wojciech Zareba,et al. Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial , 2011, Circulation.
[25] F. Romeo,et al. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes. , 2011, Heart rhythm.
[26] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[27] Wilfried Mullens,et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. , 2009, Journal of the American College of Cardiology.
[28] C. Schneider,et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.
[29] D. Exner,et al. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy , 2008, Journal of Interventional Cardiac Electrophysiology.
[30] J. Daubert,et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects , 2001, Heart.